-
EP1957673
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1957673
| EP1957673 - MATERIALS AND METHODS FOR ABCB1 POLYMORPHIC VARIANT SCREENING, DIAGNOSIS, AND TREATMENT [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.10.2012 Database last updated on 22.01.2025 | Most recent event Tooltip | 26.10.2012 | Application deemed to be withdrawn | published on 28.11.2012 [2012/48] | Applicant(s) | For all designated states Government of the United States of America, Represented by the Secretary, Department of Health and Human Services Office of Technology Transfer 6011 Executive Boulevard, Suite 325 Rockville, Maryland 20852 / US | [2008/34] | Inventor(s) | 01 /
FIGG, William D. 10451 Breckinridge LN Fairfax, VA 22030 / US | 02 /
SPARREBOOM, Alexander 187 Ridgefield Road Memphis, TN 38111 / US | 03 /
SISSUNG, Tristan M. 4708 Randolph Court Annandale, VA 22003 / US | 04 /
PIEKARZ, Richard L. 1424 Crestridge Drive Silver Spring, MD 20910 / US | 05 /
BATES, Susan E. 5404 Alta Vista Road Bethesda, MD 20814 / US | [2008/43] |
| Former [2008/34] | 01 /
FIGG, William D. 10451 Breckinridge LN Fairfax, VA 22030 / US | ||
| 02 /
SPARREBOOM, Alexander 187 Ridgefield Road Memphis, TN 38111 / US | |||
| 03 /
SISSUNG, Tristan M. 4708 Randolph Court Annandale, VA 22003 / US | |||
| 04 /
PIEKARZ, Richard L. 8708 First Ave. Silver Spring, MD 20910 / US | |||
| 05 /
BATES, Susan E. 5404 Alta Vista Road Bethesda, MD 20814 / US | Representative(s) | Pfenning, Meinig & Partner mbB Patent- und Rechtsanwälte Theresienhöhe 11a 80339 München / DE | [N/P] |
| Former [2008/34] | Pfenning, Meinig & Partner GbR Patent- und Rechtsanwälte Theresienhöhe 13 80339 München / DE | Application number, filing date | 06837251.5 | 09.11.2006 | [2008/34] | WO2006US43656 | Priority number, date | US20050736083P | 10.11.2005 Original published format: US 736083 P | [2008/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2007058896 | Date: | 24.05.2007 | Language: | EN | [2007/21] | Type: | A2 Application without search report | No.: | EP1957673 | Date: | 20.08.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.05.2007 takes the place of the publication of the European patent application. | [2008/34] | Search report(s) | International search report - published on: | EP | 04.10.2007 | Classification | IPC: | C12Q1/68 | [2008/34] | CPC: |
C12Q1/6883 (EP,US);
C12Q2600/106 (EP,US);
C12Q2600/156 (EP,US);
C12Q2600/172 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/34] | Title | German: | MATERIALIEN UND VERFAHREN ZUM SCREENING, ZUR DIAGNOSE UND BEHANDLUNG POLYMORPHER ABCB1-VARIANTEN | [2008/34] | English: | MATERIALS AND METHODS FOR ABCB1 POLYMORPHIC VARIANT SCREENING, DIAGNOSIS, AND TREATMENT | [2008/34] | French: | MATERIAUX ET PROCEDES POUR UN CRIBLAGE DE VARIANTS POLYMORPHES ABCB1, DIAGNOSTIC ET TRAITEMENT | [2008/34] | Entry into regional phase | 04.06.2008 | National basic fee paid | 04.06.2008 | Designation fee(s) paid | 04.06.2008 | Examination fee paid | Examination procedure | 04.06.2008 | Amendment by applicant (claims and/or description) | 04.06.2008 | Examination requested [2008/34] | 05.11.2008 | Despatch of a communication from the examining division (Time limit: M04) | 26.02.2009 | Reply to a communication from the examining division | 01.06.2012 | Application deemed to be withdrawn, date of legal effect [2012/48] | 09.07.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2012/48] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 05.11.2008 | Fees paid | Renewal fee | 25.11.2008 | Renewal fee patent year 03 | 25.11.2009 | Renewal fee patent year 04 | 24.11.2010 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 30.11.2011 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO03013535 (EPIDAUROS BIOTECHNOLOGIE AG [DE], et al) [X] 56,59 * claims 1,3,9,18,20,24-26,37 *; | [X]WO2004016759 (RAUCY JUDY [US]) [X] 56,59,60 * abstract * * example 6 *; | [X]WO2004057030 (PFIZER PROD INC [US], et al) [X] 1-55,62 * claims 1-4 *; | [X] - XIAO JIM J ET AL, "Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-eth ylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicycl o[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell lines.", THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS JUL 2005, (200507), vol. 314, no. 1, ISSN 0022-3565, pages 467 - 475, XP002442474 [X] 56-58,60 * abstract * * section "Real-time RT-PCR" * * page 468, column 1, paragraph 1 * DOI: http://dx.doi.org/10.1124/jpet.105.083956 | [X] - KROETZ D L ET AL, "Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene", PHARMACOGENETICS, CHAPMAN & HALL, LONDON, GB, (200308), vol. 13, no. 8, ISSN 0960-314X, pages 481 - 494, XP002982428 [X] 56-58 * page 483, column 1, paragraph L - column 2, paragraph 1 * * page 483, column 2, paragraph 3 * DOI: http://dx.doi.org/10.1097/00008571-200308000-00006 | [X] - CLARK DAVID W J ET AL, "Linking pharmacovigilance with pharmacogenetics.", DRUG SAFETY : AN INTERNATIONAL JOURNAL OF MEDICAL TOXICOLOGY AND DRUG EXPERIENCE 2004, (2004), vol. 27, no. 15, ISSN 0114-5916, pages 1171 - 1184, XP009086760 [X] 60 * abstract * * page 1172, column 1, paragraph L * * page 1179, column 2, paragraph L * DOI: http://dx.doi.org/10.2165/00002018-200427150-00002 | [X] - SANDOR V ET AL, "PHASE I TRIAL OF THE HISTONE DEACETYLASE INHIBITOR, DEPSIPEPTIDE (FR901228, NSC 630176), IN PATIENTS WITH REFRACTORY NEOPLASMS", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, (200203), vol. 8, no. 3, ISSN 1078-0432, pages 718 - 728, XP009012362 [X] 60 * abstract * | [X] - "Human MDR1 related DNA sequence SEQ ID NO:674.", Geneseq, (20031204), Database accession no. ADB92124, URL: EBI, XP002443350 [X] 56,59 * the whole document * | [X] - "Human MDR1 related DNA sequence SEQ ID NO:673.", Geneseq, (20031204), Database accession no. ADB92123, URL: EBI, XP002443351 [X] 56,59 * the whole document * | [A] - MEISSNER KONRAD ET AL, "Modulation of multidrug resistance P-glycoprotein 1 (ABCB1) expression in human heart by hereditary polymorphisms", PHARMACOGENETICS, CHAPMAN & HALL, LONDON, GB, (200406), vol. 14, no. 6, ISSN 0960-314X, pages 381 - 385, XP009086699 [A] * abstract * DOI: http://dx.doi.org/10.1097/00008571-200406000-00007 | [PX] - SHAH MANISHA H ET AL, "Cardiotoxicity of histone deacetylase inhibitor depsipeptide in patients with metastatic neuroendocrine tumors.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 1 JUL 2006, (20060701), vol. 12, no. 13, ISSN 1078-0432, pages 3997 - 4003, XP002443312 [PX] 60 * abstract * DOI: http://dx.doi.org/10.1158/1078-0432.CCR-05-2689 | Examination | - John L. Marshall ET AL, "A phase I trial of Depsipeptide (FR901228) in patients with advanced cancer", Journal of Experimental Therapeutics and Oncology, (20021101), vol. 2, no. 6, doi:10.1046/j.1359-4117.2002.01039.x, ISSN 1359-4117, pages 325 - 332, XP055023132 DOI: http://dx.doi.org/10.1046/j.1359-4117.2002.01039.x |